期刊文献+

大肠埃希菌产超广谱β-内酰胺酶的基因型研究及耐药分析 被引量:6

Research on genotype and drug resistance of extended spectrumβ-lactamase produced in Escherichia coli
原文传递
导出
摘要 目的探究贵州黔西南州大肠埃希菌产超广谱β-内酰胺酶(ESBLs)的基因型及耐药率。方法收集样本,从512个样本中选取大肠埃希菌共208例,对株菌行ESBLs表型确证,再对确证的产ESBLs大肠埃希菌行基因型检测,并对菌株行耐药检测。结果在208株大肠埃希菌中,其中ESBLs大肠埃希菌共有61株,阳性率为29.33%;产ESBLs对哌拉西林、氨苄西林、头孢唑林、头孢呋辛、头孢噻肟、头胞哌酮/舒巴坦和头胞噻肟/舒巴坦的耐药率明显高于非产ESBLs菌株(均P<0.05),产ESBLs大肠埃希菌对美罗培南和亚胺培南耐药率均表现为0;PCR法检测最常见基因型为CTX-M-1型ESBLs,检出率为6.55%。部分菌株同时产2种ESBLs。结论 ESBLs细菌检出率高,对美罗培南和亚胺培南的耐药,基因以CTX-M-1为主,其次是CTX-M-9。 Objective To investigate the genotype and drug resistance rate of extended spectrum β- lactamase produced in Escherichia coli. Methods 208 strains of Escherichia coli were collected from 512 samples,and the phenotype confirmatory of them was performed; The genotype and drug resistance of the confirmed E. coli producing ESBLs were detected. Results In208 strains of E. coli,61 were defined as ones producing ESBLs,and the positive rate of E. coli was 29. 33%. The drug resistance rate of ESBLs- producing strains to most antibiotics( piperacillin,ampicillin,cefazolin,cefuroxime,cefotaxime,cefoperazone / shubatan head cell and the first cell of cefotaxime / sulbactam) was significantly higher than in non- ESBLs producing strains( all P 〈 0. 05). The drug resistance rates of ESBLs- producing E. coli to meropenem and imipenem were 0%. The most frequent β- lactamase type was cefotaximase one( CTX- M- 1,6. 55%). Parts of strains could simultaneously produce2 kinds of ESBLs. Conclusion The detection rate of ESBLs strains was higher,the drug resistance to meropenem and imipenem,CTX- M- 1 was major in the genes,followed by CTX- M- 9.
出处 《中国卫生检验杂志》 北大核心 2014年第24期3619-3621,共3页 Chinese Journal of Health Laboratory Technology
关键词 大肠埃希菌 耐药性 Β-内酰胺酶类 基因型 Escherichia coli Drug-risistance β-lactamase Genotype
  • 相关文献

同被引文献67

  • 1程训民,张琪,沈继录,朱素珍,李敏,徐元宏.产超广谱β-内酰胺酶表型及基因型分布[J].中华医院感染学杂志,2005,15(2):142-145. 被引量:35
  • 2陆承平.兽医微生物学[M].北京:中国农业出版社,2007:196-197.
  • 3Petrackovd D,Janetek J,Bezouskovd S,et al. Fitness and pro-teome changes accompanying the development of erythromycin resistance in a population of Escherichia coli grown in continu- ous culture [J].Microbiologyopen,2013,2(5):841-852.
  • 4Alrowais H, McElheny C L,Spychala C N, et al.Fosfomycin re- sistance in E. coli, pennsylvania, USA [ J 7. Emerging Infectious Diseases,2015 ,21(11) :2045-2047.
  • 5Pilmis B, Delory T, Groh M, et al. Extended-spectrum beta- lactamase-producing Enterobacteriaceae (ESBL-PE) infec- tions:are carbapenem alternatives achievable in daily practice rJ].Int J Infect Dis,2015,39:62-67.
  • 6Tseng S P,Wang S F,Kuo C Y,et al.Characterization of los {omycin resistant extended-spectrum :-lactamase-producing Escherichla coli isolates from human and pig in Taiwan[J]. PLoS One,2015,10(8) : 1-14.
  • 7Clinical and Laborarory Standards Institute(CISI). MIO0 -$25 Performance standards for antimicrobial susceptibility testing; Twen- ty - Fifth Informational Supplement [ S ]. Wayne : CLSI, 2015.
  • 8Yano H, Ogawa M, Endo S, et al. mong clinical isolates of Metallo - High frequency of IMP - 6 a- 13- Lactamase- Producing Escherichia coli in Japan [J]. Antimicrob Agents Chemother 2012, 56(8) : 4554 -4555.
  • 9Van Duin D, Kaye KS, Neuner EA, et al. Carbapenem - resistant Enterobacteriaceae : a review of treatment and outcomes [ J ]. Diagn Microbiol Infect Dis, 2013, 75(2) : 115 -120.
  • 10Nordmann P, Dortet L, Poirel L. Carbepenem resistance in Enter- obacteriaceae: here is the storm! [J]. Trends Mol Med, 2012, 18 (5) : 263 -271.

引证文献6

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部